We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Samsung Biologics announced a strong year in 2020 as it reported 1 trillion won in target sales within just a decade at its 10th Annual General Meeting (AGM) on March 19th Korea time.
Samsung Biologics has appointed John Rim as its president and chief executive officer. The appointment was made effective immediately and formalized via the company’s board of directors meeting yesterday.